[Abnormal cutaneous, mucous & subinguinal pigmentation in nivaquine & flavoquine therapy of 2 cases of chronic lupus erythematosus].
D000655:Amodiaquine; D000962:Antimalarials / Q000009:adverse effects*; D002738:Chloroquine / Q000009:adverse effects*; D006801:Humans; D008179:Lupus Erythematosus, Discoid / Q000628:therapy*; D008180:Lupus Erythematosus, Systemic; D010858:Pigmentation; D010859:Pigmentation Disorders
D000962:Antimalarials; D000655:Amodiaquine; D002738:Chloroquine
ANTIMALARIALS/injurious effects; CHLOROQUINE/injurious effects; LUPUS ERYTHEMATOSUS, DISCOID/therapy; PIGMENTATION
Pigmentation anormale cutanéo-muqueuse et sous-unguéale au cours du traitement par la nivaquine et la flavoquine de deux cas de lupus érythémateux chronique.